Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 803598, 10 pages
http://dx.doi.org/10.1155/2014/803598
Research Article

Borderline Ovarian Tumors and Diagnostic Dilemma of Intraoperative Diagnosis: Could Preoperative He4 Assay and ROMA Score Assessment Increase the Frozen Section Accuracy? A Multicenter Case-Control Study

1Department of Woman and Child Health, University of Padua, 35128 Padua, Italy
2Dipartimento di Salute della Donna e del Bambino, U.O.C. di Ginecologia e Ostetricia, Via Giustiniani 3, 35128 Padova, Italy
3Department of Surgical Sciences, University of Parma, 43100 Parma, Italy
4Department of Medical Diagnostic and Special Therapy, University of Padua, 35128 Padua, Italy
5Gynaecologic and Obstetric Units, Vicenza General Hospital, 36100 Vicenza, Italy
6Department of Obstetrics and Gynaecology, University of Verona, 37100 Verona, Italy
7Department of Laboratory Medicine, University of Padua, 35128 Padua, Italy

Received 25 February 2014; Revised 11 August 2014; Accepted 3 September 2014; Published 5 November 2014

Academic Editor: David G. Mutch

Copyright © 2014 Salvatore Gizzo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Morice, C. Uzan, R. Fauvet, S. Gouy, P. Duvillard, and E. Darai, “Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence,” The Lancet Oncology, vol. 13, no. 3, pp. e103–e115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C. L. Trimble, C. Kosary, and E. L. Trimble, “Long-term survival and patterns of care in women with ovarian tumors of low malignant potential,” Gynecologic Oncology, vol. 86, no. 1, pp. 34–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. K. Shih, Q. Zhou, J. Huh et al., “Risk factors for recurrence of ovarian borderline tumors,” Gynecologic Oncology, vol. 120, no. 3, pp. 480–484, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Timmerman, B. Van Calster, A. C. Testa et al., “Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group,” Ultrasound in Obstetrics and Gynecology, vol. 36, no. 2, pp. 226–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Holcomb, Z. Vucetic, M. C. Miller, and R. C. Knapp, “Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women,” The American Journal of Obstetrics and Gynecology, vol. 205, no. 4, pp. 358.e1–358.e6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. T. S. Patrelli, R. Berretta, S. Gizzo et al., “CA 125 serum values in surgically treated endometriosis patients and its relationships with anatomic sites of endometriosis and pregnancy rate,” Fertility and Sterility, vol. 95, no. 1, pp. 393–396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Prat, “Staging classification for cancer of the ovary, fallopian tube, and peritoneum,” International Journal of Gynecology and Obstetrics, vol. 124, no. 1, pp. 1–5, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Ilvan, R. Ramazanoglu, E. U. Akyildiz, Z. Calay, T. Bese, and N. Oruc, “The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses,” Gynecologic Oncology, vol. 97, no. 2, pp. 395–399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. B. Tempfer, S. Polterauer, E.-K. Bentz, A. Reinthaller, and L. A. Hefler, “Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: a retrospective analysis of 96 cases and review of the literature,” Gynecologic Oncology, vol. 107, no. 2, pp. 248–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Taskiran, O. Erdem, A. Onan et al., “The role of frozen section evaluation in the diagnosis of adnexal mass,” International Journal of Gynecological Cancer, vol. 18, no. 2, pp. 235–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Rakhshan, H. Zham, and M. Kazempour, “Accuracy of frozen section diagnosis in ovarian masses: experience at a tertiary oncology center,” Archives of Gynecology and Obstetrics, vol. 280, no. 2, pp. 223–228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Kim, T. J. Kim, Y. G. Park et al., “Clinical analysis of intra-operative frozen section proven borderline tumors of the ovary,” Journal of Gynecologic Oncology, vol. 20, no. 3, pp. 176–180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Gizzo, E. Ancona, T. S. Patrelli et al., “Fertility preservation in young women with cervical cancer: an oncologic dilemma or a new conception of fertility sparing surgery?” Cancer Investigation, vol. 31, no. 3, p. 189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nassir, S. Darb-Esfahani, R. Richter et al., “HE4 tissue expression in borderline ovarian tumors: a pilot study by the tumorbank ovarian cancer network,” Anticancer Research, vol. 33, no. 4, pp. 1673–1677, 2013. View at Google Scholar · View at Scopus
  15. W. R. Hart and H. J. Norris, “Borderline and malignant mucinous tumors of the ovary. Histologic criteria and clinical behavior,” Cancer, vol. 31, no. 5, pp. 1031–1045, 1973. View at Publisher · View at Google Scholar · View at Scopus
  16. R. E. Scully, Atlas of Tumor Pathology. Tumors of the Ovary and Maldeveloped Gonads, Armed Forces Institute of Pathology, Washington, DC, USA, 1979.
  17. S. Gizzo, E. Ancona, C. Saccardi, D. D'Antona, G. B. Nardelli, and M. Plebani, “Could kidney glomerular filtration impairment represent the “Achilles heel” of HE4 serum marker? A possible further implication,” Clinical Chemistry and Laboratory Medicine, vol. 52, pp. e45–e46, 2014. View at Google Scholar
  18. M. Plebani, “HE4 in gynecological cancers: report of a European investigators and experts meeting,” Clinical Chemistry and Laboratory Medicine, vol. 50, no. 12, pp. 2127–2136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Song, C. H. Choi, H.-J. Kim et al., “Accuracy of frozen section diagnosis of borderline ovarian tumors,” Gynecologic Oncology, vol. 122, no. 1, pp. 127–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Kumpulainen, T. Kuoppala, A. Leminen et al., “Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland,” Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 5, pp. 610–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Gultekin, O. E. Gultekin, B. Cingillioglu, S. Sayhan, M. Sanci, and Y. Yildirim, “The value of frozen section evaluation in the management of borderline ovarian tumors,” Journal of Cancer Research and Therapeutics, vol. 7, no. 4, pp. 416–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Yarandi, Z. Eftekhar, N. Izadi-Mood, and H. Shojaei, “Accuracy of intraoperative frozen section in the diagnosis of ovarian tumors,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 48, no. 4, pp. 438–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Geomini, G. Bremer, R. Kruitwagen, and B. W. J. Mol, “Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis,” Gynecologic Oncology, vol. 96, no. 1, pp. 1–9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Houck, N. Nikrui, L. Duska et al., “Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis,” Obstetrics and Gynecology, vol. 95, no. 6, pp. 839–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-L. Brun, A. Cortez, R. Rouzier et al., “Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors,” The American Journal of Obstetrics and Gynecology, vol. 199, no. 3, pp. 244.e1–244.e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Berretta, M. Rolla, T. S. Patrelli, D. Gramellini, G. M. Fadda, and G. B. Nardelli, “Incidence of port-site metastasis after laparoscopic management of borderline ovarian tumors: a series of 22 patients,” European Journal of Gynaecological Oncology, vol. 30, no. 3, pp. 300–302, 2009. View at Google Scholar · View at Scopus
  27. S. Takemoto, K. Ushijima, R. Kawano et al., “Validity of intra-operative diagnosis in laparoscopic surgery for ovarian tumors,” Journal of Minimally Invasive Gynecology, vol. 21, no. 4, pp. 576–579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Chapron, J.-B. Dubuisson, O. Kadoch, S. Capella-Allouc, and M. C. Vacher-Lavenu, “Laparoscopic management of organic ovarian cysts: is there a place for frozen section diagnosis?” Human Reproduction, vol. 13, no. 2, pp. 324–329, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Canis, R. Mashiach, A. Wattiez et al., “Frozen section in laparoscopic management of macroscopically suspicious ovarian masses,” Journal of the American Association of Gynecologic Laparoscopists, vol. 11, no. 3, pp. 365–369, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Romagnolo, A. Gadducci, E. Sartori, P. Zola, and T. Maggino, “Management of borderline ovarian tumors: results of an Italian multicenter study,” Gynecologic Oncology, vol. 101, no. 2, pp. 255–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Zannoni, L. Savelli, L. Jokubkiene et al., “Intra- and interobserver agreement with regard to describing adnexal masses using International Ovarian Tumor Analysis terminology: reproducibility study involving seven observers,” Ultrasound in Obstetrics and Gynecology, vol. 44, no. 1, pp. 100–108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Manegold-Brauer, A. K. Bellin, S. Tercanli, O. Lapaire, and V. Heinzelmann-Schwarz, “The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging,” Archives of Gynecology and Obstetrics, vol. 289, no. 3, pp. 491–498, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Franchi, T. S. Patrelli, R. Berretta et al., “Role of d-dimer testing in severe pelvic inflammatory disease: a new usable marker to assess the need for fertility-impairing surgery?” Fertility and Sterility, vol. 94, no. 6, pp. 2372–2375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. R. G. Moore, A. K. Brown, M. C. Miller et al., “The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass,” Gynecologic Oncology, vol. 108, no. 2, pp. 402–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Montagnana, E. Danese, S. Giudici et al., “HE4 in ovarian cancer: from discovery to clinical application,” Advances in Clinical Chemistry, vol. 55, pp. 1–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. M. T. Sandri, F. Bottari, D. Franchi et al., “Comparison of HE4, CA125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome,” Gynecologic Oncology, vol. 128, no. 2, pp. 233–238, 2013. View at Publisher · View at Google Scholar · View at Scopus